S-TESTOSTERONE ULTRA 250MG/ML MDV IN SESAME OIL (TEST CYP 200MG/TEST PROP 25MG/NANDROLONE DECA 25MG) Rx Only, 10ml glass vial Red Mountain Compounding Rx.
Class I - DangerousWhat Should You Do?
- Check if you have this product: Lot #:S07132019DT@01, Exp 10/13/19;S07312019DH@05, Exp 10/31/19 S06122019DT@09, Exp 9/12/19;
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
- Reason for Recall:
- Lack of Assurance of Sterility
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- terminated
Product Information
Full Description:
S-TESTOSTERONE ULTRA 250MG/ML MDV IN SESAME OIL (TEST CYP 200MG/TEST PROP 25MG/NANDROLONE DECA 25MG) Rx Only, 10ml glass vial Red Mountain Compounding Rx.
Product Codes/Lot Numbers:
Lot #:S07132019DT@01, Exp 10/13/19;S07312019DH@05, Exp 10/31/19 S06122019DT@09, Exp 9/12/19;
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: D-0292-2020
Related Recalls
PYRIDOXINE HCL (B6) 100MG/ML MDV, Red Mountain Compounding Rx
First Royal Care Co. LLC
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
METHYLCOBALAMIN 10,000MCG/ML MDV INJ, Rx only, Red Mountain Compounding Rx
First Royal Care Co. LLC
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
TEST CYP 50MG/ML IN ETHYL OLEATE OIL, Rx only, Red Mountain Compounding Rx
First Royal Care Co. LLC
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns